Healthcare Quality, Patient Safety & PolicySarepta Launches ELEVIDYS Gene Therapy Commercially in JapanBusiness WireFebruary 25, 2026February 26, 2026 by Business WireFebruary 25, 2026February 26, 2026014 – Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years – Company is eligible to receive...
